Original Article

Modern Pathology (2007) 20, 760–769; doi:10.1038/modpathol.3800795; published online 27 April 2007

Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series

The opinions and assertions contained herein are the expressed views of the authors and are not to be construed as official or reflecting the views of the Departments of the Army or Defense. This is a US Government work, and as such is in the public domain in the United States of America.

Paul H Hartel1, Julie C Fanburg-Smith2, Aletta A Frazier3,5, Jeffrey R Galvin3,5, Jack H Lichy4, Konstantin Shilo1 and Teri J Franks1

  1. 1Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
  2. 2Department of Orthopedic and Soft Tissue, Armed Forces Institute of Pathology, Washington, DC, USA
  3. 3Department of Radiologic Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
  4. 4Department of Molecular Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
  5. 5Department of Diagnostic Radiology, University of Maryland School of Medicine, Baltimore, MD, USA

Correspondence: Dr TJ Franks, MD, Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, 6825 16th Street NW, Building 54, Room 2071, Washington, DC 20306-6000, USA. E-mail: frankst@afip.osd.mil

Received 24 January 2007; Revised 17 March 2007; Accepted 27 March 2007; Published online 27 April 2007.

Top

Abstract

Primary pulmonary and mediastinal synovial sarcoma is rare and poses a diagnostic challenge particularly when unusual histological features are present. We present 60 cases of primary pulmonary and mediastinal synovial sarcoma (29 male and 27 female subjects; mean age, 42 years) and compare our results with five prior series to better define unusual histological features. Clinically, patients with mediastinal synovial sarcoma were younger with a male gender bias. Radiologically, tumors were well delineated with distinctive magnetic resonance imaging features and little vascular enhancement. In all, 21/46 patients died of disease within 5 years. Histologically, all tumors had dense cellularity, interlacing fascicles, hyalinized stroma, and mast cell influx. Hemangiopericytoma-like vasculature (48/60), focal myxoid change (30/60), and entrapped pneumocytes (23/60) were seen. Calcification was not prevalent (10/60). Unusual histological features included Verocay body-like formations (7/60), vague rosettes (6/60), well-formed papillary structures (3/60), adenomatoid change (3/60), and rhabdoid morphology (2/60). Immunohistochemistry demonstrated expression of pancytokeratin (39/58), epithelial membrane antigen (29/53), cytokeratin 7 (26/40), cytokeratin 5/6 (5/7), calretinin (15/23), CD99 (19/23), bcl-2 (24/24), CD56 (11/11), S-100 (9/51), and smooth muscle actin (8/32). In total, 92% (36/39) of primary pulmonary and mediastinal synovial sarcomas studied were positive for t(x;18). In conclusion, our study confirms the clinical, histological, immunohistochemical, and molecular data from previous large series of primary pulmonary and mediastinal synovial sarcoma. Compared with soft tissue synovial sarcoma, primary pulmonary and mediastinal synovial sarcoma has less calcification, less obvious mast cell influx, and less radiologic vascularity, but similar magnetic resonance imaging features, percentage of poorly differentiated tumors, and number of t(x;18)-positive tumors. Awareness of focal unusual histology can prevent misdiagnosis particularly in t(x;18)-negative tumors.

Keywords:

pulmonary, pleura, mediastinum, synovial sarcoma

Extra navigation

.

naturejobs

ADVERTISEMENT